EA202090087A3 - 1,2,4-OXADIAZOLE AND THIADIAZOLIC COMPOUNDS AS IMMUNOMODULATORS - Google Patents

1,2,4-OXADIAZOLE AND THIADIAZOLIC COMPOUNDS AS IMMUNOMODULATORS

Info

Publication number
EA202090087A3
EA202090087A3 EA202090087A EA202090087A EA202090087A3 EA 202090087 A3 EA202090087 A3 EA 202090087A3 EA 202090087 A EA202090087 A EA 202090087A EA 202090087 A EA202090087 A EA 202090087A EA 202090087 A3 EA202090087 A3 EA 202090087A3
Authority
EA
Eurasian Patent Office
Prior art keywords
oxadiazole
compounds
thiadiazolic
immunomodulators
inhibiting
Prior art date
Application number
EA202090087A
Other languages
Russian (ru)
Other versions
EA202090087A2 (en
Inventor
Поттайил Говиндан Наир Сасикумар
Муралидхара Рамачандра
Ситхарамая Сетти Сударсхан Наремаддепалли
Original Assignee
Ауриджен Дискавери Текнолоджис Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ауриджен Дискавери Текнолоджис Лимитед filed Critical Ауриджен Дискавери Текнолоджис Лимитед
Publication of EA202090087A2 publication Critical patent/EA202090087A2/en
Publication of EA202090087A3 publication Critical patent/EA202090087A3/en

Links

Abstract

Настоящее изобретение относится к 1,2,4-оксадиазольным и тиадиазольным соединениям формулы (I) и их применению для ингибирования сигнального пути запрограммированной гибели клетки 1 (PD1) и/или для лечения нарушений путем ингибирования иммуносупрессивного сигнала, индицированного PD-1, PD-L1 или PD-L2.The present invention relates to 1,2,4-oxadiazole and thiadiazole compounds of formula (I) and their use for inhibiting the programmed cell death 1 (PD1) signaling pathway and / or for treating disorders by inhibiting the immunosuppressive signal indicated by PD-1, PD- L1 or PD-L2.

EA202090087A 2015-03-10 2016-03-07 1,2,4-OXADIAZOLE AND THIADIAZOLIC COMPOUNDS AS IMMUNOMODULATORS EA202090087A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1180CH2015 2015-03-10

Publications (2)

Publication Number Publication Date
EA202090087A2 EA202090087A2 (en) 2020-11-30
EA202090087A3 true EA202090087A3 (en) 2020-12-30

Family

ID=73649890

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202090087A EA202090087A3 (en) 2015-03-10 2016-03-07 1,2,4-OXADIAZOLE AND THIADIAZOLIC COMPOUNDS AS IMMUNOMODULATORS

Country Status (1)

Country Link
EA (1) EA202090087A3 (en)

Also Published As

Publication number Publication date
EA202090087A2 (en) 2020-11-30

Similar Documents

Publication Publication Date Title
PH12017501454A1 (en) 1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
EA201791629A1 (en) 1,3,4-OXADIAZOL AND TIADIAZOLIC CONNECTIONS AS IMMUNOMODULATORS
EA201791634A1 (en) 3-SUBSTITUTE 1,3,4-OXADIAZOLE AND TIADIAZOLE COMPOUNDS AS IMMUNOMODULATORS
PH12017501455A1 (en) 3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
PH12017501456A1 (en) Therapeutic cyclic compounds as immunomodulators
EA201990997A1 (en) VISTA DOUBLE INHIBITORS AND WAYS PD-1
CY1122986T1 (en) 1,2,4-OXADIAZOLE DERIVATIVES AS IMMUNE MODULATORS
EA201600234A1 (en) 1,3,4-OXADIAZOLE AND 1,3,4-TIADIAZOLE DERIVATIVES AS AN IMMUNOMODULATOR
EA201600235A1 (en) CYCLIC PEPTIDOMYMETIC COMPOUNDS AS IMMUNOMODULATORS
PH12015502611A1 (en) Heterocyclic compounds as hedgehog signaling pathway inhibitors
PH12020550511A1 (en) Dual inhibitors of tim-3 and pd-1 pathways
EA202090087A3 (en) 1,2,4-OXADIAZOLE AND THIADIAZOLIC COMPOUNDS AS IMMUNOMODULATORS